オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - enalapril maleate, quantity: 10 mg - tablet, uncoated - excipient ingredients: hypromellose; maleic acid; iron oxide red; zinc stearate; maize starch; lactose monohydrate - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - enalapril maleate, quantity: 20 mg - tablet, uncoated - excipient ingredients: hypromellose; lactose monohydrate; iron oxide red; maleic acid; zinc stearate; iron oxide yellow; maize starch - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - enalapril maleate, quantity: 5 mg - tablet, uncoated - excipient ingredients: maleic acid; zinc stearate; maize starch; hypromellose; lactose monohydrate - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - enalapril maleate, quantity: 10 mg - tablet, uncoated - excipient ingredients: maize starch; sodium bicarbonate; lactose monohydrate; iron oxide red; purified talc; magnesium stearate - indications: hypertension. all grades of essential hypertension; renovascular hypertension. congestive heart failure. treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril sandoz be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - enalapril maleate -

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - enalapril maleate, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; hypromellose; maleic acid; croscarmellose sodium; sodium stearylfumarate - hypertension ,enalapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. ,congestive heart failure ,enalapril is indicated for the treatment of all degrees of symptomatic heart failure. in such patients, it is recommended that enalapril be administered together with a diuretic. ,left ventricular dysfunction ,all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35 percent, irrespective of the presence or severity of obvious symptoms of heart failure.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

viatris limited - enalapril maleate 10mg;  ;  ; enalapril maleate 10mg - tablet - 10 mg - active: enalapril maleate 10mg     excipient: iron oxide red lactose monohydrate magnesium stearate maize starch sodium bicarbonate starch active: enalapril maleate 10mg excipient: iron oxide red lactose monohydrate magnesium stearate maize starch sodium bicarbonate starch - · all grades of essential hypertension. · renovascular hypertension.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - enalapril maleate, quantity: 10 mg; lercanidipine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: titanium dioxide; purified talc; povidone; lactose monohydrate; hypromellose; magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a; sodium bicarbonate; macrogol 6000 - treatment of hypertension. treatment should not be initiated with these fixed dose combinations. (see dosage and administration).

カナダ - 英語 - Health Canada

aa pharma inc - enalapril maleate; hydrochlorothiazide - tablet - 10mg; 25mg - enalapril maleate 10mg; hydrochlorothiazide 25mg - angiotensin-converting enzyme inhibitors

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - enalapril maleate, quantity: 10 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; maize starch; iron oxide red; iron oxide yellow; sodium bicarbonate; lactose monohydrate; magnesium stearate - auspril tablets are indicated in the treatment of: hypertension: all grades of essential hypertension renovascular hypertension. congestive heart failure: all degrees of symptomatic heart failure. in such patients, it is recommended that auspril be administered together with a diuretic. left ventricular dysfunction: all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.